A low-cost assay to detect multiple early-stage cancers from just one millilitre of blood for better decisions on referral in primary care, save lives and to help pharma access patients earlier.
Following the success of three accelerator programmes we have clinical validation of this assay and more novel IP in the pipeline for wider disease indications and metastatic therapy, all developed on non-diluting funds.
Company Details
- Employees
- 3
- Founded
- 2020
- Address
- Gipsy Lane, Bioinnovation Hub,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://metaguidex.com/
- Keywords
- Oxford.
- HQ
- Oxford, Oxfordshire
Metaguidex Ltd Questions
Metaguidex Ltd's website is https://metaguidex.com/
Metaguidex Ltd's LinkedIn profile is https://uk.linkedin.com/company/metaguidex-ltd
Metaguidex Ltd has
3 employees.
View email and phone details for 3
employees at Metaguidex Ltd.
Metaguidex Ltd's industry is
Biotechnology Research
Metaguidex Ltd's top competitors are
Samphire Neuroscience,
Amref Health Africa,
Neuro-Bio Ltd,
Cell And Gene Therapy Catapult,
Evox Therapeutics Ltd,
Apsida Life Science,
Ellison Institute Of Technology Oxford,
Nhs Clinical Entrepreneur Programme,
Oxford Target Therapeutics Ltd,
The London Genetics Centre.
Metaguidex Ltd's categories are Biotechnology Research
Metaguidex Ltd's founding year is 2020
